Cognition Therapeutics, Inc. ( NASDAQ:CGTX – Get Rating ) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 128,900 shares, an increase of 56.6% from the March 15th total of 82,300 shares. Approximately 0.6% of the shares of the stock are short sold. Based on an average daily volume of 77,100 shares, the short-interest ratio is presently 1.7 days. Institutional Trading of Cognition Therapeutics Several hedge funds have recently modified their holdings of CGTX.

https://www.dailypolitical.com/2023/04/16/cognition-therapeutics-inc-nasdaqcgtx-short-interest-up-56-6-in-march.html

#dailypolitical